20.11.Z - Manufacture of industrial gases
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.99.Z - Other manufacturing notelsewhere classified
33.12.Z - Repair and maintenance of machinery
33.20.Z - Installation of industrial machinery and equipment and outfit
38.32.Z - Recovery of sorted materials
46.18.Z - Agents specialised in the sale of other particular products
46.46.Z - Wholesale of pharmaceutical goods
46.75.Z - Wholesale of chemical products
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 506,9 | 478,1 | 554 | 15,9 |
Liabilities and provisions | 375,1 | 323,5 | 600,5 | 85,6 |
Equity | 504,5 | 522,7 | 586,7 | 12,2 |
Total assets | 879,7 | 846,2 | 1187,1 | 40,3 |
Cash and cash equivalents | 1,1 | 1,7 | 2,2 | 30,7 |
Depreciation | 55,3 | 46,6 | 46,4 | -0,3 |
Gross profit / loss | 86,2 | 67,7 | 129,2 | 90,8 |
EBITDA | 124,8 | 128,1 | 160,1 | 25 |
Net profit / loss | 71,9 | 55,3 | 113,9 | 106,1 |
Operating profit (EBIT) | 69,4 | 81,5 | 113,7 | 39,5 |
Current assets | 224,6 | 174,5 | 196,5 | 12,6 |
% | % | % | p.p. | |
Return on equity (ROE) | 14,2 | 10,6 | 19,4 | 8,8 |
Return on sales (ROS) | 14,2 | 11,6 | 20,6 | 9 |
Equity ratio | 57,4 | 61,8 | 49,4 | -12,4 |
EBITDA margin | 24,6 | 26,8 | 28,9 | 2,1 |
Gross profit margin | 17 | 14,2 | 23,3 | 9,1 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 103 | 103 | 123 | 20 |
Current ratio | 1,4 | 1,2 | 1 | -0,2 |
Net debt to EBITDA | 2 | 1,6 | 3 | 1,4 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.